Effectiveness of a cytolysin-enriched vaccine for protection of cattle against infectious bovine keratoconjunctivitis

Lisle W. George, Andrew J. Borrowman, John A Angelos

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective - To determine the immunogenicity of a Moraxella bovis cytolysin-enriched vaccine for prevention of infectious bovine keratoconjunctivitis (IBK). Animals - 104 mixed-breed beef calves ranging between 4 and 8 months of age. Procedure - Vaccines were prepared by the diafiltration of broth culture supernatant from hemolytic M bovis or sterile media. The diafiltered retentate was combined with Quil A adjuvant. Calves were randomly assigned to receive either the cytolysin vaccine (n = 35) or, as controls, adjuvant (35) or saline (0.9% NaCl) solution (34). Eyes of all calves were examined weekly for signs of IBK for 15 weeks. Calves that developed severe IBK were treated SC with florfenicol. Results - Cytolysin vaccine contained 4 proteins with molecular masses ranging between 65 and 90 kd. Cytolysin-vaccinated calves had fewer instances of IBK than control calves. The time of onset of corneal lesions in cytolysin-vaccinated calves that developed IBK was delayed, compared with that of calves in either control group. The cytolysin-Quil A vaccine contained endotoxin, but calves did not have clinical signs of illness after vaccination. Conclusions and Clinical Relevance - Calves that were vaccinated with a cytolysin-enriched vaccine had some resistance to IBK. Vaccines containing concentrated diafiltered M bovis cytolysin could protect beef calves against IBK.

Original languageEnglish (US)
Pages (from-to)136-142
Number of pages7
JournalAmerican Journal of Veterinary Research
Volume66
Issue number1
DOIs
StatePublished - Jan 2005

Fingerprint

Infectious Keratoconjunctivitis
Perforin
keratoconjunctivitis
Vaccines
calves
vaccines
cattle
Moraxella (Moraxella) bovis
adjuvants
beef
corneal diseases
Moraxella bovis
Endotoxins
florfenicol
Vaccination
endotoxins

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Effectiveness of a cytolysin-enriched vaccine for protection of cattle against infectious bovine keratoconjunctivitis. / George, Lisle W.; Borrowman, Andrew J.; Angelos, John A.

In: American Journal of Veterinary Research, Vol. 66, No. 1, 01.2005, p. 136-142.

Research output: Contribution to journalArticle

@article{7670a187691f41589acb04fe062344f4,
title = "Effectiveness of a cytolysin-enriched vaccine for protection of cattle against infectious bovine keratoconjunctivitis",
abstract = "Objective - To determine the immunogenicity of a Moraxella bovis cytolysin-enriched vaccine for prevention of infectious bovine keratoconjunctivitis (IBK). Animals - 104 mixed-breed beef calves ranging between 4 and 8 months of age. Procedure - Vaccines were prepared by the diafiltration of broth culture supernatant from hemolytic M bovis or sterile media. The diafiltered retentate was combined with Quil A adjuvant. Calves were randomly assigned to receive either the cytolysin vaccine (n = 35) or, as controls, adjuvant (35) or saline (0.9{\%} NaCl) solution (34). Eyes of all calves were examined weekly for signs of IBK for 15 weeks. Calves that developed severe IBK were treated SC with florfenicol. Results - Cytolysin vaccine contained 4 proteins with molecular masses ranging between 65 and 90 kd. Cytolysin-vaccinated calves had fewer instances of IBK than control calves. The time of onset of corneal lesions in cytolysin-vaccinated calves that developed IBK was delayed, compared with that of calves in either control group. The cytolysin-Quil A vaccine contained endotoxin, but calves did not have clinical signs of illness after vaccination. Conclusions and Clinical Relevance - Calves that were vaccinated with a cytolysin-enriched vaccine had some resistance to IBK. Vaccines containing concentrated diafiltered M bovis cytolysin could protect beef calves against IBK.",
author = "George, {Lisle W.} and Borrowman, {Andrew J.} and Angelos, {John A}",
year = "2005",
month = "1",
doi = "10.2460/ajvr.2005.66.136",
language = "English (US)",
volume = "66",
pages = "136--142",
journal = "American Journal of Veterinary Research",
issn = "0002-9645",
publisher = "American Veterinary Medical Association",
number = "1",

}

TY - JOUR

T1 - Effectiveness of a cytolysin-enriched vaccine for protection of cattle against infectious bovine keratoconjunctivitis

AU - George, Lisle W.

AU - Borrowman, Andrew J.

AU - Angelos, John A

PY - 2005/1

Y1 - 2005/1

N2 - Objective - To determine the immunogenicity of a Moraxella bovis cytolysin-enriched vaccine for prevention of infectious bovine keratoconjunctivitis (IBK). Animals - 104 mixed-breed beef calves ranging between 4 and 8 months of age. Procedure - Vaccines were prepared by the diafiltration of broth culture supernatant from hemolytic M bovis or sterile media. The diafiltered retentate was combined with Quil A adjuvant. Calves were randomly assigned to receive either the cytolysin vaccine (n = 35) or, as controls, adjuvant (35) or saline (0.9% NaCl) solution (34). Eyes of all calves were examined weekly for signs of IBK for 15 weeks. Calves that developed severe IBK were treated SC with florfenicol. Results - Cytolysin vaccine contained 4 proteins with molecular masses ranging between 65 and 90 kd. Cytolysin-vaccinated calves had fewer instances of IBK than control calves. The time of onset of corneal lesions in cytolysin-vaccinated calves that developed IBK was delayed, compared with that of calves in either control group. The cytolysin-Quil A vaccine contained endotoxin, but calves did not have clinical signs of illness after vaccination. Conclusions and Clinical Relevance - Calves that were vaccinated with a cytolysin-enriched vaccine had some resistance to IBK. Vaccines containing concentrated diafiltered M bovis cytolysin could protect beef calves against IBK.

AB - Objective - To determine the immunogenicity of a Moraxella bovis cytolysin-enriched vaccine for prevention of infectious bovine keratoconjunctivitis (IBK). Animals - 104 mixed-breed beef calves ranging between 4 and 8 months of age. Procedure - Vaccines were prepared by the diafiltration of broth culture supernatant from hemolytic M bovis or sterile media. The diafiltered retentate was combined with Quil A adjuvant. Calves were randomly assigned to receive either the cytolysin vaccine (n = 35) or, as controls, adjuvant (35) or saline (0.9% NaCl) solution (34). Eyes of all calves were examined weekly for signs of IBK for 15 weeks. Calves that developed severe IBK were treated SC with florfenicol. Results - Cytolysin vaccine contained 4 proteins with molecular masses ranging between 65 and 90 kd. Cytolysin-vaccinated calves had fewer instances of IBK than control calves. The time of onset of corneal lesions in cytolysin-vaccinated calves that developed IBK was delayed, compared with that of calves in either control group. The cytolysin-Quil A vaccine contained endotoxin, but calves did not have clinical signs of illness after vaccination. Conclusions and Clinical Relevance - Calves that were vaccinated with a cytolysin-enriched vaccine had some resistance to IBK. Vaccines containing concentrated diafiltered M bovis cytolysin could protect beef calves against IBK.

UR - http://www.scopus.com/inward/record.url?scp=13444293172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13444293172&partnerID=8YFLogxK

U2 - 10.2460/ajvr.2005.66.136

DO - 10.2460/ajvr.2005.66.136

M3 - Article

C2 - 15691049

AN - SCOPUS:13444293172

VL - 66

SP - 136

EP - 142

JO - American Journal of Veterinary Research

JF - American Journal of Veterinary Research

SN - 0002-9645

IS - 1

ER -